• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Neuronetics

edit

Neuronetics, Inc. is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. Based in Malvern, PA, they are the leader in the development of TMS Therapy (transcranial magnetic stimulation), a non-invasive form of neuromodulation.

Recent Milestones

edit

• 
  Neuronetics received $30M in Series E funding. (5/16/11)
  Posted 5/20/11 at 3:32am via marketwire.com
• 
  Neuronetics received $30M in Series D funding. (10/27/09)
  Posted 10/27/09 at 11:49pm via onbiovc.com

Videos

Screenshots

edit

Above: Neuronetics
Uploaded: 10/28/09

Sources

1. Neuronetics, Inc.: Series D $30M (onbiovc.com) [edit]
2. Neuronetics, Inc. Raises $30 Million in Series E Financing (marketwire.com) [edit]